Skip to main content
. 2021 Mar 15;11:615986. doi: 10.3389/fonc.2021.615986

Table 4.

Univariate analysis of clinical and radiographic characteristics for PFS.

Characteristics N 24th month PFS rate (%) HR 95% CI P
Hyperintense T2 proportion 0–74% 6 83.3 1 0.27
≥75% 32 55.5 1.42 0.76–2.65
Hyperintense T1 CE proportion 0-74% 11 100 1 0.02*
≥75% 27 43.1 3.37 1.23–9.25
Size (mm) 1–49 11 80.0 1 0.15
≥50 27 51.0 3.0 0.67–13.27
Tumor volume(mm3) 1–96590 18 69.9 1 0.27
≥96590 20 50.0 37 0.63–5.35
Age(year) 1–29 18 71.4 1 0.13
≥29 20 47.7 2.31 0.79–6.81
Sex Male 12 90.9 1 0.05
Female 26 45.1 4.35 0.98–19.20
Dominant shape Round/oval 7 42.9 1 0.60
Lobulated 14 70.7 0.51 0.13–2.03 0.34
Infiltrative 17 57.0 0.83 0.24–2.84 0.77
Multifocality No 28 58.6 1 0.87
Yes 10 60.0 0.91 0.29–2.87
Adjacent structure involvement None 10 46.7 1 0.86
Adjacent 9 66.7 0.81 0.22–3.01 0.75
Encased 14 55.0 0.97 0.29–3.25 0.96
Invaded 5 80.0
Compartment of origin Deep fascial/intermuscular 27 62.0 1
Intramuscular 8 72.9 1.00 0.32–3.16
Superficial fascial 2 0 1.00 0.06–12.32
Subcutaneous 1 0 /

*P < 0.05; CI, confidence interval; HR, hazard ratio.